Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Yoon, Sung-Soo  [Clear All Filters]
2024
Kook HWon, Jang JEun, Min C-K, Yoon DHyun, Kim K, Bang S-M, Park Y, Lee JHoon, Yoon S-S, Kim JSeok. A Multicenter Analysis of Clinical Features and Long-Term Outcomes of POEMS Syndrome in Korea. J Korean Med Sci. 2024;39(2):e5.
Kim J, Byun JMin, Hong J, Koh Y, Shin D-Y, Kim TMin, Yoon S-S, Park H, Kim I. Treatment outcomes and prognostic factors of patients with lymphoblastic lymphoma in East Asia. Medicine (Baltimore). 2024;103(7):e37100.
2023
Kim M, Lee J-J, Min C-K, Lee JYun, Jo J-C, Yoon S-S, Lim S-N, Do YRok, Kim K, Lee JHoon, et al. Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015). Ann Hematol. 2023.
Park W, Byun JMin, Hong J, Kim I, Shin D-Y, Park S, Koh Y, Yoon S-S. Comparison of the effect of DLI according to cell sources in relapsed AML after allogeneic stem cell transplantation. Ann Hematol. 2023.
Röth A, Ichikawa S, Ito Y, Kim JSeok, Nagy Z, Obara N, Panse J, Schrezenmeier H, Sica S, Soret J, et al. Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trial. Eur J Haematol. 2023.
Cho H, Yoon DHyun, Shin D-Y, Koh Y, Yoon S-S, Kim SJin, Do YRok, Lee G-W, Kwak J-Y, Park Y, et al. Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404). Cancer Res Treat. 2023.
Jung EHee, Byun JMin, Shin D-Y, Do YRok, Jo J-C, Lee SMin, Yoon S-S. Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122). Cancer Med. 2023.
Liu J, Min S, Kim D, Park J, Park E, Pei S, Koh Y, Shin D-Y, Byun JMin, Ko M, et al. Pharmacological GLUT3 salvage augments the efficacy of vitamin C-induced TET2 restoration in acute myeloid leukemia. Leukemia. 2023.
Hong J, Park H-K, Chang S-H, Byun JMin, Shin D-Y, Koh Y, Yoon S-S, Choi Y, Kim I. A randomized phase II study of acyclovir for the prevention of chemotherapy-induced oral mucositis in patients undergoing autologous hematopoietic stem cell transplantation. BMC Oral Health. 2023;23(1):1008.
2022
Kim DHyun, Seo J, Shin D-Y, Koh Y, Hong J, Kim I, Yoon S-S, Byun JMin. Reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for patients with myelofibrosis. Blood Res. 2022.
2021
Jung EHee, Shin D-Y, Hong J, Kim I, Yoon S-S, Koh Y, Byun JMin. Identification of an Optimal Population for Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Mature T and NK Cell Neoplasms. In Vivo. 2021;35(4):2379-2390.
Kong SGim, Lee J-H, Lim YTak, Lee JHyun, Eom H-S, Lee H, Kim DYoung, Lim S-N, Yoon S-S, Kim S-Y, et al. Influence of creatinine levels on survival in patients with veno-occlusive disease treated with defibrotide. Korean J Intern Med. 2021.
2019
Yang H-M, Kim J-Y, Cho H-J, Lee J-E, Jin S, Hur J, Kwon Y-W, Seong M-W, Choi E-K, Lee H-Y, et al. NFATc1+CD31+CD45- circulating multipotent stem cells derived from human endocardium and their therapeutic potential. Biomaterials. 2019;232:119674.
Hwang SMee, Kim S-M, Nam Y, Kim J, Kim S, Ahn Y-O, Park Y, Yoon S-S, Shin S, Kwon S, et al. Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemia. Leuk Res. 2019;84:106190.
Jabbour EJ, Gökbuget N, Kantarjian HM, Thomas X, Larson RA, Yoon S-S, Ghobadi A, Topp MS, Tran Q, Franklin JL, et al. Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 study. Cancer. 2019.
2018
Jeong SHyun, Song H-N, Park JSeong, Yang D-H, Koh Y, Yoon S-S, Lee HWon, Eom HSeok, Won J-H, Kim WSeog, et al. Allogeneic stem cell transplantation for patients with natural killer/T-cell lymphoid malignancy: a multicenter analysis comparing upfront and salvage transplantation. Biol Blood Marrow Transplant. 2018.
Lee G-W, Park SWoo, Go S-I, Kim H-G, Kim MKyoung, Min C-K, Kwak J-Y, Bae S-B, Yoon S-S, Lee J-J, et al. The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma. Acta Haematol. 2018;140(3):146-156.
2016
Byun JMin, Kim H-L, Shin D-Y, Koh Y, Yoon S-S, Seong M-W, Park SSup, Kim JHee, Lee Y-G, Kim I. The Impact of Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Methotrexate Prophylaxis. PLoS One. 2016;11(10):e0163998.
2015
Yoo J-J, Cho EJu, Cho YYoun, Lee M, Lee DHyeon, Cho Y, Lee J-H, Yu SJong, Yoon S-S, Yoon J-H, et al. Efficacy of antiviral prophylaxis in HBsAg-negative, anti-HBc positive patients undergoing hematopoietic stem cell transplantation. Liver Int. 2015.
Park H, Rho EYoun, In JWon, Kim I, Yoon S-S, Park S, Shin S, Park KUn, Song EYoung. The Impact of HLA and KIR Ligand Mismatching on Unrelated Allogeneic Hematopoietic Stem Cell Transplantation in Korean Adult Patients. Ann Lab Med. 2015;35(1):111-7.
2013
Kim SJin, Yoon DHyun, Yang D-H, Eom HSeok, Cho SGoo, Yoon S-S, Lee JHoon, Kim WSeog, Suh C. Plerixafor use for peripheral blood stem cell mobilization in Korea. Blood Res. 2013;48(2):72-3.